| Identification | Back Directory | [Name]
EMpagliflozin iMpurity 14 | [CAS]
2137418-13-2 | [Synonyms]
Empagliflozin-13
Empagliflozin Impurity 64
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[hydroxy[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran-
3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-
pyran-3,4,5-triol
Empagliflozin impurity 16/(2S,3R,4R,5S,6R)-2-(4-chloro-3-(hydroxy(4-(((S)-tetrahydrofuran- 3-yl)oxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol | [Molecular Formula]
C23H27ClO8 | [MDL Number]
MFCD31434091 | [MOL File]
2137418-13-2.mol | [Molecular Weight]
466.91 |
| Hazard Information | Back Directory | [Uses]
Hydroxy Empagliflozin is an impurity of Empagliflozin (E521510), a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats. |
|
|